Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations

Antonio Passaro; Tony Mok; Solange Peters; Sanjay Popat; Myung‐Ju Ahn; Filippo de Marinis

doi:10.1016/j.jtho.2020.12.002

Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations

著者: Antonio Passaro, Tony Mok, Solange Peters, Sanjay Popat, Myung‐Ju Ahn, Filippo de Marinis - Journal of Thoracic Oncology 2020 被引用: 213

Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations | Litlas